(object) array( 'id' => '1461048', 'url' => 'SR/phase_ii_trials', 'image' => '', 'title' => 'Druga faza ispitivanja', 'tags' => array ( 0 => 'Druga faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Druga faza ispitivanja', 'source_id' => 30917, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Kontrolisane kliničke studije koje se sprovode sa ciljem procene efikasnosti leka za određenu indikaciju ili indikacije kod pacijenta sa oboljenjem ili stanjem koje se ispituje kao i determinacije uobičajenih kratkotrajnih neželjenih dejstava i rizka.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247811, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase ii trials', 'Definition' => 'Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_ii_trials', )

(object) array( 'id' => '1461318', 'url' => 'SR/price_ceiling', 'image' => '', 'title' => 'maksimalna cena', 'tags' => array ( 0 => 'maksimalna cena', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'maksimalna cena', 'source_id' => 54604, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Maksimalna cena može biti određena bilo zakonskim ili tržišnim uslovima.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862277, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'price ceiling', 'Definition' => 'The maximum the price can be set, whether by law or market conditions.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'price_ceiling', )

(object) array( 'id' => '1467647', 'url' => 'SR/study_type', 'image' => '', 'title' => 'tip studje', 'tags' => array ( 0 => 'tip studje', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'tip studje', 'source_id' => 30943, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110709204525', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Primarne tehnike ispitivanja korišćene u protokolu observacije; tipovi su Svrha, Trajanje, Selekcija i Tajming', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999174033410, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'study type', 'Definition' => 'The primary investigative techniques used in an observational protocol; types are Purpose, Duration, Selection, and Timing.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'study_type', )

(object) array( 'id' => '1460562', 'url' => 'SR/pharmaceuticals', 'image' => '', 'title' => 'lekovi', 'tags' => array ( 0 => 'lekovi', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'lekovi', 'source_id' => 114398, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20110705074504', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Hemijska supstanca koja se koristi u medicinske svrhe, uključujući dijagnostiku, lečenje ili prevenciju bolesti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964534325248, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'pharmaceuticals', 'Definition' => 'Chemical substance for medical purposes, including diagnosis, treatment and prevention of disease.', 'Synonym' => 'medicine_₀', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Drugs', 'Industry' => 'Pharmaceutical', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/7/20', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'pharmaceuticals', )

(object) array( 'id' => '1461047', 'url' => 'SR/phase_i_trials', 'image' => '', 'title' => 'Prva faza ispitivanja', 'tags' => array ( 0 => 'Prva faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Prva faza ispitivanja', 'source_id' => 30916, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155509', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Početne studije sa ciljem određivanja metabolizma i farmakološkog dejstva lekova na čoveka, neželjena dejstva vezana za povećane doze, kao i sticanja ranog uvida u efikasnost leka; može uključiti ispitanike bez zdravstvenih problema odnosno pacijente.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247810, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase i trials', 'Definition' => 'Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_i_trials', )

(object) array( 'id' => '1460609', 'url' => 'SR/confidentiality_regarding_trial_participants', 'image' => '', 'title' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'tags' => array ( 0 => 'poverljivost podataka učesnika u kliničkom ispitivanju', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'source_id' => 30883, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705083507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na poštovanje poverljivosti podataka učesnika u kliničkom ispitivanju uključujući njihov identitet i sve lične medicinskwe informacije. Odobrenje za korišćenje dobijenih podataka radi verifikacije samih podataka mora unapred biti dobijeno od učesnika ispitivanja kao i uverenje da poverljivost mora biti zagarantovana.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964695805952, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'confidentiality regarding trial participants', 'Definition' => 'Refers to maintaining the confidentiality of trial participants including their personal identity and all personal medical information. The trial participants\' consent to the use of records for data verification purposes should be obtained prior to the trial and assurance must be given that confidentiality will be maintained.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'confidentiality_regarding_trial_participants', )

(object) array( 'id' => '1461003', 'url' => 'SR/data_safety_and_monitoring_board_(dsmb)', 'image' => '', 'title' => 'Odbor za bezbednost podataka i monitoring', 'tags' => array ( 0 => 'Odbor za bezbednost podataka i monitoring', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Odbor za bezbednost podataka i monitoring', 'source_id' => 30887, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152003', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Nezavisni odbor koji se sastoji od predstavnika udruženja i stručnjaka za klinička ispitivanja koji vrše pregled podataka u toku samog kliničkog ispitivanja radi sigurnosti da učestnici nisu izloženi nepotrebnom riziku. ovaj Odbor(DSMB)može predložiti okončanje ispitivanja ukoliko postoji sumnja u bezbedenost iii ukoliko su ciljevi ispitivanja postignuti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907777, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'data safety and monitoring board (dsmb)', 'Definition' => 'An independent committee, composed of community representatives and clinical research experts, that reviews data while a clinical trial is in progress to ensure that participants are not exposed to undue risk. A DSMB may recommend that a trial be stopped if there are safety concerns or if the trial objectives have been achieved.', 'Synonym' => 'DSMB_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'data_safety_and_monitoring_board_(dsmb)', )

(object) array( 'id' => '1467657', 'url' => 'SR/Lotronex', 'image' => '', 'title' => 'Lotronex', 'tags' => array ( 0 => 'Lotronex', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lotronex', 'source_id' => 31150, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju sindroma iritabilnog kolona kod žena', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845763, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lotronex', 'Definition' => 'a prescription drug used to treat IBS in women', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lotronex', )

(object) array( 'id' => '1467656', 'url' => 'SR/Lamisil', 'image' => '', 'title' => 'Lamisil', 'tags' => array ( 0 => 'Lamisil', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamisil', 'source_id' => 31149, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210504', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'antibiotik koji se koristi u lečenju gljivičnog oboljenja noktiju na prstima stopala', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845762, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamisil', 'Definition' => 'an antibiotic used to treat toenail fungus', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamisil', )

(object) array( 'id' => '1461088', 'url' => 'SR/convention_₅', 'image' => '', 'title' => 'konvencija', 'tags' => array ( 0 => 'konvencija', 1 => 'Language', 2 => 'Terminology', 3 => '', ), 'term' => 'konvencija', 'source_id' => 1080723, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Terminology', ), 'lastedit' => '20110705163519', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Sporazum, uglavnom jednosglasno postignut od strane govornika zajednice, da se povezanost mora primenjivati između lingvističkih jedinica, između ovih i dpoljnog sveta ili primeniti pri upotrebi gramatičkih pravila datij jezika.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966616797187, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'convention', 'Definition' => 'An agreement, usually reached unconsciously by speakers in a community, that relationships are to apply between linguistic items, between these and the outside world or to apply in the use of rules in the grammar of their language.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Language', 'Product Category' => 'Terminology', 'Creation User' => 'nunk0410', 'Creation Date' => '2011/4/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'convention_₅', )